Addition of Baricitinib to COVID-19 Treatment Does Not Increase Bacterial Infection Compared to Standard Therapy: A Single-center Retrospective Study

OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic continues to spread across the world, and the utility of many drugs for treatment has been suggested. However, few studies have examined the efficacy and safety of treatment with baricitinib, remdesivir, and dexamethasone. METHODS: A retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobe, Hiroshi, Ito, Akihiro, Nakanishi, Yosuke, Kuriyama, Akira, Tachibana, Hiromasa, Ishida, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424089/
https://www.ncbi.nlm.nih.gov/pubmed/35650130
http://dx.doi.org/10.2169/internalmedicine.9534-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424089/
https://www.ncbi.nlm.nih.gov/pubmed/35650130
http://dx.doi.org/10.2169/internalmedicine.9534-22

Ejemplares similares